GT
MLAB icon

Glenmede Trust’s Mesa Laboratories MLAB Stock Holding History

Glenmede Trust’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$17.4M Sell
146,544
-5,303
-3% -$723K 0.09% 199
2024
Q4 		$20M Buy
151,847
+54,513
+56% +$6.69M 0.1% 199
2024
Q3 		$12.6M Sell
97,334
-1,442
-1% -$170K 0.06% 325
2024
Q2 		$8.57M Buy
98,776
+703
+0.7% +$73.6K 0.04% 377
2024
Q1 		$10.8M Buy
98,073
+7,190
+8% +$724K 0.05% 353
2023
Q4 		$9.52M Sell
90,883
-3,454
-4% -$337K 0.05% 365
2023
Q3 		$9.91M Buy
94,337
+44,002
+87% +$5.64M 0.06% 337
2023
Q2 		$8.66M Buy
50,335
+79
+0.2% +$12K 0.05% 360
2023
Q1 		$8.78M Sell
50,256
-930
-2% -$167K 0.05% 359
2022
Q4 		$8.51M Sell
51,186
-7,083
-12% -$1.11M 0.05% 349
2022
Q3 		$8.21M Sell
58,269
-8,749
-13% -$1.6M 0.05% 354
2022
Q2 		$13.7M Sell
67,018
-6,254
-9% -$1.37M 0.08% 277
2022
Q1 		$18.7M Sell
73,272
-130
-0.2% -$35.3K 0.09% 261
2021
Q4 		$24.1M Sell
73,402
-361
-0.5% -$113K 0.11% 205
2021
Q3 		$22.3M Sell
73,763
-995
-1% -$283K 0.12% 201
2021
Q2 		$20.3M Sell
74,758
-355
-0.5% -$90K 0.1% 223
2021
Q1 		$18.3M Buy
75,113
+48,409
+181% +$13.3M 0.1% 231
2020
Q4 		$7.65M Buy
26,704
+17,873
+202% +$4.92M 0.04% 353
2020
Q3 		$2.25M Buy
8,831
+1,702
+24% +$404K 0.01% 476
2020
Q2 		$1.54M Buy
7,129
+2,691
+61% +$620K 0.01% 530
2020
Q1 		$1.11M Hold
4,438
– – 0.01% 725
2019
Q4 		$1.11M Buy
4,438
+2,153
+94% +$504K 0.01% 725
2019
Q3 		$542 Buy
2,285
+558
+32% +$129K ﹤0.01% 875
2019
Q2 		$421 Sell
1,727
-22
-1% -$5.12K ﹤0.01% 948
2019
Q1 		$403 Sell
1,749
-70
-4% -$15.8K ﹤0.01% 948
2018
Q4 		$378 Buy
1,819
+769
+73% +$150K ﹤0.01% 920
2018
Q3 		$193K Hold
1,050
– – ﹤0.01% 1156
2018
Q2 		$222K Hold
1,050
– – ﹤0.01% 1037
2018
Q1 		$130K Hold
1,050
– – ﹤0.01% 1310
2017
Q4 		$130K Sell
1,050
-15
-1% -$2.1K ﹤0.01% 1310
2017
Q3 		$158K Sell
1,065
-210
-16% -$29.6K ﹤0.01% 1301
2017
Q2 		$156K Hold
1,275
– – ﹤0.01% 1272
2017
Q1 		$156K Hold
1,275
– – ﹤0.01% 1272
2016
Q4 		$156K Buy
1,275
+100
+9% +$12.5K ﹤0.01% 1274
2016
Q3 		$134K Hold
1,175
– – ﹤0.01% 1316
2016
Q2 		$144K Sell
1,175
-75
-6% -$8.08K ﹤0.01% 1268
2016
Q1 		$119K Buy
1,250
+150
+14% +$13.5K ﹤0.01% 1287
2015
Q4 		$108K Hold
1,100
– – ﹤0.01% 1336
2015
Q3 		$121K Hold
1,100
– – ﹤0.01% 1327
2015
Q2 		$97K Hold
1,100
– – ﹤0.01% 1427
2015
Q1 		$78K Hold
1,100
– – ﹤0.01% 1536
2014
Q4 		$84K Sell
1,100
-750
-41% -$54.9K ﹤0.01% 1582
2014
Q3 		$106K Sell
1,850
-75
-4% -$5.44K ﹤0.01% 1451
2014
Q2 		$161K Hold
1,925
– – ﹤0.01% 1248
2014
Q1 		$173K Sell
1,925
-250
-11% -$21.2K ﹤0.01% 1225
2013
Q4 		$170K Buy
2,175
+25
+1% +$1.82K ﹤0.01% 1203
2013
Q3 		$144K Hold
2,150
– – ﹤0.01% 1251
2013
Q2 		$115K Buy
+2,150
New +$112K ﹤0.01% 1265

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Glenmede Trust's MLAB Position: Q1 2025 in Review

Glenmede Trust reduced its Mesa Laboratories (MLAB) stake by 3.5% in Q1 2025, selling an estimated $723K and leaving 146,544 shares worth $17.4M. The position accounts for 0.09% of the portfolio, ranked #199.

Glenmede Trust first reported a position in MLAB in Q2 2013 and has held it in 48 quarters since. The position peaked at $24.1M in Q4 2021. 151 funds tracked by Wall St. Rank hold MLAB as of Q1 2025.

  • Glenmede Trust held 146,544 shares of Mesa Laboratories worth $17.4M as of Q1 2025.
  • Glenmede Trust sold 5,303 Mesa Laboratories shares in Q1 2025, an estimated $723K.
  • Mesa Laboratories made up 0.09% of Glenmede Trust's portfolio in Q1 2025, its #199 holding.
  • Glenmede Trust first reported a position in Mesa Laboratories in Q2 2013 and has held it in 48 quarters since.
  • Glenmede Trust's Mesa Laboratories position peaked at $24.1M in Q4 2021.
  • 151 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2025.

Based on Glenmede Trust's 13F filing for Q1 2025, filed 15 May 2025.